AUD 0.02
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -1.29 Million | -1.57 Million | -974.42 Thousand | -1.07 Million | -845.24 Thousand | -378.37 Thousand |
Net Income | 13.97 Million | -7.96 Million | -15.67 Million | 20.06 Million | -2.22 Million | -2.6 Million |
Depreciation & Amortization | 5508.00 | 5825.00 | 6393.00 | 5082.00 | 5230.00 | 2.26 Million |
Deferred income taxes | - | -472.2 Thousand | -133.77 Thousand | -509.58 Thousand | -312.81 Thousand | 35.74 Thousand |
Stock-based compensation | 75.88 Thousand | 173.92 Thousand | 9002.00 | 495.07 Thousand | 73.97 Thousand | 253.84 Thousand |
Change in working capital | -31.2 Thousand | -476.59 Thousand | -44.91 Thousand | -14.85 Thousand | -119.11 Thousand | -289.58 Thousand |
Other non-cash items | -15.32 Million | 7.16 Million | 14.86 Million | -21.11 Million | 1.73 Million | -35.74 Thousand |
Investing Cash Flow | 8.4 Million | -1.26 Million | -395.64 Thousand | 1.73 Million | -1.37 Million | -2.49 Million |
Investments in PPE | -2.49 Million | -2.01 Million | -658.67 Thousand | -1.09 Million | -1.04 Million | -2.47 Million |
Acquisitions | - | 547.00 | - | 521.59 Thousand | - | - |
Investment purchases | - | -30.33 Thousand | - | -426.48 Thousand | -334.82 Thousand | - |
Sales/Maturities of investments | 100.77 Thousand | 779.91 Thousand | 3031.00 | 2.73 Million | - | - |
Other Investing Activities | 10.9 Million | 1766.00 | 260 Thousand | 2.83 Million | -334.82 Thousand | -20 Thousand |
Financing Cash Flow | - | 2.08 Million | -5295.00 | 823.39 Thousand | 2.04 Million | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | -144.2 Thousand | -5295.00 | -71.4 Thousand | -151.24 Thousand | - |
Common Stock Issuance | - | 2.08 Million | -5295.00 | 823.39 Thousand | 2.04 Million | - |
Other Financing Activities | - | 144.2 Thousand | -5295.00 | 71.4 Thousand | 151.24 Thousand | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | 84.8 Thousand | -286.62 Thousand | -111.98 Thousand | -4352.00 | -228.38 Thousand | -387.31 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -31.2 Thousand | -189.96 Thousand | 67.06 Thousand | -10.49 Thousand | 109.26 Thousand | 97.72 Thousand |
Cash at beginning of period | 496.06 Thousand | 1.22 Million | 2.59 Million | 1.11 Million | 1.29 Million | 4.17 Million |
Cash at end of period | 7.55 Million | 496.06 Thousand | 1.22 Million | 2.59 Million | 1.11 Million | 1.29 Million |
Capital Expenditure | -2.49 Million | -2.01 Million | -658.67 Thousand | -1.09 Million | -1.04 Million | -2.47 Million |
Effect of forex changes on cash | -49.91 Thousand | 29.48 Thousand | 3527.00 | -5193.00 | -2002.00 | - |
Net cash flow / Change in cash | 7.05 Million | -726.3 Thousand | -1.37 Million | 1.47 Million | -181.38 Thousand | -2.87 Million |
Free Cash Flow | -3.79 Million | -3.59 Million | -1.63 Million | -2.17 Million | -1.88 Million | -2.85 Million |
Breakdown | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 4.04 Million | 9.93 Million | -1.65 Million | -7.96 Million | -6.31 Million | -15.67 Million |
Depreciation & Amortization | 2883.00 | 2625.00 | 2947.00 | 5825.00 | 2878.00 | 6393.00 |
Deferred income taxes | - | - | 178.71 Thousand | -472.2 Thousand | - | -133.77 Thousand |
Stock-based compensation | - | 75.88 Thousand | 5358.00 | 173.92 Thousand | 168.56 Thousand | 9002.00 |
Change in working capital | -31.2 Thousand | - | -189.96 Thousand | -476.59 Thousand | - | -44.91 Thousand |
Other non-cash items | -4.57 Million | -10.75 Million | 979.39 Thousand | 7.16 Million | 5.42 Million | 14.86 Million |
Investing Cash Flow | -1.01 Million | 9.42 Million | -434.8 Thousand | -1.26 Million | -831.79 Thousand | -395.64 Thousand |
Investments in PPE | -1.01 Million | -1.48 Million | -688.53 Thousand | -2.01 Million | -1.32 Million | -658.67 Thousand |
Acquisitions | - | 10.79 Million | - | 547.00 | 547.00 | - |
Investment purchases | - | - | - | -30.33 Thousand | -30.33 Thousand | - |
Sales/Maturities of investments | - | 100.77 Thousand | 253.73 Thousand | 779.91 Thousand | 526.18 Thousand | 3031.00 |
Other Investing Activities | 759.00 | 10.9 Million | 253.73 Thousand | 1766.00 | 1766.00 | 260 Thousand |
Financing Cash Flow | - | 496.06 Thousand | 10.13 Thousand | 2.08 Million | 2.07 Million | -5295.00 |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | -144.2 Thousand | - | -5295.00 |
Common Stock Issuance | - | - | 10.13 Thousand | 2.08 Million | 2.07 Million | -5295.00 |
Other Financing Activities | - | - | 10.13 Thousand | 144.2 Thousand | 2.07 Million | -5295.00 |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | -286.62 Thousand | - | -111.98 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -31.2 Thousand | - | -189.96 Thousand | -189.96 Thousand | - | 67.06 Thousand |
Cash at beginning of period | 9.09 Million | 496.06 Thousand | 1.57 Million | 1.22 Million | 1.22 Million | 2.59 Million |
Cash at end of period | 7.55 Million | 9.09 Million | 496.06 Thousand | 496.06 Thousand | 1.57 Million | 1.22 Million |
Capital Expenditure | -1.01 Million | -1.48 Million | -688.53 Thousand | -2.01 Million | -1.32 Million | -658.67 Thousand |
Effect of forex changes on cash | 30.06 Thousand | -79.97 Thousand | 25.8 Thousand | 29.48 Thousand | 3683.00 | 3527.00 |
Net cash flow / Change in cash | -1.53 Million | 8.59 Million | -1.07 Million | -726.3 Thousand | 352.73 Thousand | -1.37 Million |
Free Cash Flow | -1.56 Million | -2.22 Million | -1.36 Million | -3.59 Million | -2.22 Million | -1.63 Million |
AAREYDRUGS
SUGALDAM
SHIVAGR
JUBLPHARMA
EKH
3611